PROTEOGLYCAN 4

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 15:24:06 GMT 2023` Edited by `admin` on `Sat Dec 16 15:24:06 GMT 2023`
Protein Type	stimulating factor
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	M65IE9C8XJ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PROTEOGLYCAN 4

Common Name

English

LUBRICIN

Common Name

English

SUPERFICIAL ZONE PROTEOGLYCAN

Common Name

English

PROTEOGLYCAN 4 (HUMAN)

Common Name

English

MEGAKARYOCYTE-STIMULATING FACTOR

Common Name

English

Code System Code Type Description

DAILYMED

M65IE9C8XJ

Created by admin on Sat Dec 16 15:24:06 GMT 2023 , Edited by admin on Sat Dec 16 15:24:06 GMT 2023

PRIMARY

FDA UNII

M65IE9C8XJ

Created by admin on Sat Dec 16 15:24:06 GMT 2023 , Edited by admin on Sat Dec 16 15:24:06 GMT 2023

PRIMARY

RXCUI

2619327

Created by admin on Sat Dec 16 15:24:06 GMT 2023 , Edited by admin on Sat Dec 16 15:24:06 GMT 2023

PRIMARY

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_182
N	1_1135
N	2_182
N	2_1135
O	1_99
O	1_112
O	1_216
O	1_229
O	1_253
O	1_267
O	1_281
O	1_282
O	1_286
O	1_293
O	1_300
O	1_308
O	1_314
O	1_343
O	1_349
O	1_352
O	1_360
O	1_361
O	1_364
O	1_367
O	1_375
O	1_376
O	1_383
O	1_384
O	1_391
O	1_399
O	1_403
O	1_406
O	1_414
O	1_415
O	1_422
O	1_423
O	1_430
O	1_431
O	1_453
O	1_454
O	1_461
O	1_469
O	1_470
O	1_477
O	1_478
O	1_485
O	1_501
O	1_505
O	1_508
O	1_516
O	1_517
O	1_529
O	1_531
O	1_539
O	1_540
O	1_547
O	1_548
O	1_555
O	1_556
O	1_563
O	1_564
O	1_571
O	1_579
O	1_580
O	1_587
O	1_588
O	1_592
O	1_595
O	1_603
O	1_652
O	1_659
O	1_660
O	1_667
O	1_668
O	1_675
O	1_676
O	1_680
O	1_683
O	1_699
O	1_700
O	1_712
O	1_744
O	1_745
O	1_752
O	1_753
O	1_768
O	1_769
O	1_781
O	1_788
O	1_805
O	1_813
O	1_814
O	1_868
O	1_876
O	1_906
O	1_907
O	1_938
O	1_939
O	1_944
O	1_951
O	1_954
O	1_955
O	1_956
O	1_1015
O	1_1137
O	2_99
O	2_112
O	2_216
O	2_229
O	2_253
O	2_267
O	2_281
O	2_282
O	2_286
O	2_293
O	2_300
O	2_308
O	2_314
O	2_343
O	2_349
O	2_352
O	2_360
O	2_361
O	2_364
O	2_367
O	2_375
O	2_376
O	2_383
O	2_384
O	2_391
O	2_399
O	2_403
O	2_406
O	2_414
O	2_415
O	2_422
O	2_423
O	2_430
O	2_431
O	2_453
O	2_454
O	2_461
O	2_469
O	2_470
O	2_477
O	2_478
O	2_485
O	2_501
O	2_505
O	2_508
O	2_516
O	2_517
O	2_529
O	2_531
O	2_539
O	2_540
O	2_547
O	2_548
O	2_555
O	2_556
O	2_563
O	2_564
O	2_571
O	2_579
O	2_580
O	2_587
O	2_588
O	2_592
O	2_595
O	2_603
O	2_652
O	2_659
O	2_660
O	2_667
O	2_668
O	2_675
O	2_676
O	2_680
O	2_683
O	2_699
O	2_700
O	2_712
O	2_744
O	2_745
O	2_752
O	2_753
O	2_768
O	2_769
O	2_781
O	2_788
O	2_805
O	2_813
O	2_814
O	2_868
O	2_876
O	2_906
O	2_907
O	2_938
O	2_939
O	2_944
O	2_951
O	2_954
O	2_955
O	2_956
O	2_1015
O	2_1137

Related Record Type Details


					SMV73KW49C

ENSEREPTIDE

ACTIVATOR OF EXPRESSION->TARGET

Comments:

Increased expression of PRG4 mRNA in tendons treated with rabPXL01 in HA, but not in tendon sheaths. In addition, treatment with rabPXL01 in HA led to repression of the mRNA levels for the pro-inflammatory mediators interleukin (IL)-1β, IL-6, and IL-8 in tendon sheaths.

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL